Neil B. Minkoff, MD: What’s the underlying pathology or pathophysiology that’s leading to all of this cost? Ahmar U. Zaidi, MD: Our understanding of what exactly is happening in sickle cell disease ...

“In our study, Black patients with TED presented with fewer clinical exam features based on current classification guidelines, but had longer follow-up and underwent similar treatments as White ...

Please provide your email address to receive an email when new articles are posted on . In a real-world cohort of more than 2,000 U.S. patients with psoriatic arthritis, most had multidomain ...

STAMFORD, Conn., Feb. 28, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced its contributions to ...

REDWOOD CITY, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company” or “Allakos”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of ...

Like their causative mutations, pathophysiology and natural history, the clinical presentation of inborn errors of immunity (IEI) varies widely. Nevertheless, some features, above all recurrent and/or ...

Neurodegenerative disorders have been reported in elite athletes who participated in contact sports. The incidence of neurodegenerative disease among former professional soccer players has not been ...

BOSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare ...

AC Immune Announces Upcoming Industry Symposium on Parkinson’s Disease and Presentation at AD/PD™ 2026 AC Immune to host symposium highlighting ...

-- Chiesi’s abstract presentations will focus on clinical insights and patient-reported outcomes inFabry disease and alpha-mannosidosis -- -- These scientific contributions in lysosomal storage ...